We are pleased to invite you to attend to the 54th International Conference on Medicinal Chemistry (RICT 2018) held in Strasbourg from Wednesday July 4 to Friday July 6.
Organized under the auspices of the French Medicinal Chemistry Society (SCT), the RICT symposium is the annual international key-event dedicated to Medicinal Chemistry and all related subjects such as Chemical Biology, Innovative Pharmaceutical Chemistry, Drug Discovery, Drug Delivery and Imaging.
This year, the congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:
• New opportunities for metabolic and cardiovascular diseases
• New breakthroughs in GPCR structure, function and their impact on drug discovery
• New modalities for challenging targets in drug discovery
• Chemical biology in drug discovery: visualizing biological processes
• Tackling challenges in drug delivery and formulation
• Case studies: from target validation to novel drugs (all therapeutic areas included)
The dead-line for abstract submission is May, 15.
Wishing to meet you in Strasbourg!
On behalf of the SCT and the organizing committee,
Dr. Luc Van-Hifte and Dr. Dominique Bonnet
Plenary speakers: Shankar BALASUBRAMANIAN (University of Cambridge, UK), Jean-Pierre BENOIT (University of Angers, France), Mark BRADLEY (University of Edinburgh, UK), Dr Anne BRUINVELS (PX HEALTHCARE, UK), Craig CREWS (University of Yale, USA), Jean-Alain FEHRENTZ (CNRS-University of Montpellier, France), Jean-Luc GALZI (CNRS-University of Strasbourg, France), A GANESAN (University of East Anglia, UK), Peter GMEINER (Friedrich Alexander University, Germany), Véronique GOUVERNEUR (University of Oxford, UK), Alexander HEIFETZ (EVOTEC, UK), Kenneth A. JACOBSON (NIDDK, USA), Manfred JUNG (Albert Ludwigs University of Freiburg, Germany), Thierry LANGER (University of Vienna, Austria), Catherine LLORENS-CORTES (INSERM-Collège de France, France), Maria Luz LOPEZ-RODRIGUEZ (Complutense University of Madrid, Spain), Christel MENET (CONFO THERAPEUTICS, Belgium), Graeme MILLIGAN (University of Glasgow, UK), Gary A. MOLANDER (University of Pennsylvania, USA), Stephan SCHANN (DOMAIN THERAPEUTICS SA, France), Patrick SCHNIDER (ROCHE Pharmaceutical, Switzerland), Nori TANAKA (RIKEN, Japan), Thomas VORHERR (NOVARTIS, Switzerland).
Keynote speakers: Julie CHARTON (University of Lille, France), Rutger FOLMER (MERCACHEM, The Netherlands), Arnaud GAUTIER (Ecole Normale Supérieure, France), Julien POTHIER (IDORSIA PHARMACEUTICALS LTD., Switzerland), Carsten SCHMECK (BAYER, Germany), Isabelle TEXIER (LETI-HEALTH, France).